Coronavirus | Oxford vaccine trial pause a wake-up call: WHO Chief Scientist Soumya Swaminathan

‘We do not have to be discouraged. These things happen.’

Updated - September 11, 2020 03:03 am IST

Published - September 11, 2020 03:00 am IST - ZURICH

Soumya Swaminathan, WHO's Chief Scientist. File

Soumya Swaminathan, WHO's Chief Scientist. File

AstraZeneca's pause of an experimental vaccine for the coronavirus after the illness of a participant is a “wake-up call” but should not discourage researchers, the World Health Organization's (WHO) chief scientist said on Thursday.

“This is a wake-up call to recognise that there are ups and downs in clinical development and that we have to be prepared,” Soumya Swaminathan told a virtual briefing from Geneva. “We do not have to be discouraged. These things happen.”

Also read: COVID-19 vaccine still possible this year: AstraZeneca

Governments are desperate for a vaccine to help end the COVID-19 pandemic, which has caused more than 900,000 deaths and global economic turmoil, and the WHO had flagged AstraZeneca's, being developed with Oxford University, as the most promising.

However, the drugmaker suspended late-stage trials this week after a participant in Britain suffered from neurological symptoms .

“It's a race against this virus, and it's a race to save lives. It's not a race between companies, and it's not a race between countries,” added WHO's head of emergencies Mike Ryan.

Also read: Coronavirus | Serum Institute pauses COVID-19 vaccine trials

More than 27.95 million people have been reported infected globally , according to a Reuters tally.

WHO epidemiologist Maria Van Kerkhove said a combination of factors is helping reduce death rates in Europe, including finding cases earlier and better clinical care.

“We are in a better position to prevent the virus from infecting vulnerable populations,” she said, cautioning, however, that the disease's long-term effects were still not known.

WHO General Director Tedros Adhanom Ghebreyesus, who on Thursday upped his fundraising plea to $38 billion for the agency's ACT Accelerator programme to fight COVID-19, declined to comment directly on reports that U.S. President Donald Trump had downplayed the virus's dangers while criticizing the WHO's response.

Also read: A necessary pause: The Hindu Editorial on the COVID-19 vaccine race

“What worries me the most is what I have been saying all along: a lack of solidarity,” Mr. Tedros said. “When we are divided, it is a good opportunity for the virus.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.